{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T17:47:27Z","timestamp":1760204847059},"reference-count":108,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2016,5,1]],"date-time":"2016-05-01T00:00:00Z","timestamp":1462060800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","cidjournal.com","clinicalkey.es","theclinics.com","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics in Dermatology"],"published-print":{"date-parts":[[2016,5]]},"DOI":"10.1016\/j.clindermatol.2016.02.006","type":"journal-article","created":{"date-parts":[[2016,2,9]],"date-time":"2016-02-09T12:55:24Z","timestamp":1455022524000},"page":"344-352","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"title":["Management of rheumatic and autoimmune blistering disease in pregnancy and postpartum"],"prefix":"10.1016","volume":"34","author":[{"given":"Joy","family":"Wan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sotonye","family":"Imadojemu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Victoria P.","family":"Werth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clindermatol.2016.02.006_bb0005","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1111\/dth.12076","article-title":"Treatment of dermatologic connective tissue disease and autoimmune blistering disorders in pregnancy","volume":"26","author":"Braunstein","year":"2013","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.clindermatol.2016.02.006_bb0010","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.clindermatol.2016.02.013","article-title":"Drug safety: pregnancy rating classifications and controversies","volume":"34","year":"2016","journal-title":"Clin Dermatol"},{"key":"10.1016\/j.clindermatol.2016.02.006_bb0015","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1186\/ar1957","article-title":"Anti-inflammatory and immunosuppressive drugs and reproduction","volume":"8","author":"Ostensen","year":"2006","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.clindermatol.2016.02.006_bb0020","doi-asserted-by":"crossref","first-page":"401.e1","DOI":"10.1016\/j.jaad.2013.09.010","article-title":"Safety of dermatologic medications in pregnancy and lactation: Part I. Pregnancy","volume":"70","author":"Murase","year":"2014","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2016.02.006_bb0025","doi-asserted-by":"crossref","first-page":"417.e1","DOI":"10.1016\/j.jaad.2013.09.009","article-title":"Safety of dermatologic medications in pregnancy and lactation: Part II. Lactation","volume":"70","author":"Butler","year":"2014","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2016.02.006_bb0030","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1002\/(SICI)1096-9926(199711)56:5<335::AID-TERA7>3.0.CO;2-W","article-title":"Population-based case\u2013control study of teratogenic potential of corticosteroids","volume":"56","author":"Czeizel","year":"1997","journal-title":"Teratology"},{"key":"10.1016\/j.clindermatol.2016.02.006_bb0035","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1034\/j.1600-0412.2002.810308.x","article-title":"Risk of intrauterine growth retardation, malformations and other birth outcomes in children after topical use of corticosteroid in pregnancy","volume":"81","author":"Mygind","year":"2002","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.clindermatol.2016.02.006_bb0040","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1002\/ajmg.a.20130","article-title":"Case\u2013control study of cleft lip or palate after maternal use of topical corticosteroids during pregnancy","volume":"120A","author":"Edwards","year":"2003","journal-title":"Am J Med Genet A"},{"key":"10.1016\/j.clindermatol.2016.02.006_bb0045","doi-asserted-by":"crossref","first-page":"585.e1","DOI":"10.1016\/j.ajog.2007.05.046","article-title":"Maternal corticosteroid use and orofacial clefts","volume":"197","author":"Carmichael","year":"2007","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.clindermatol.2016.02.006_bb0050","first-page":"CD007346","article-title":"Safety of topical corticosteroids in pregnancy","author":"Chi","year":"2009","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.clindermatol.2016.02.006_bb0055","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1038\/jid.2010.392","article-title":"Safety of topical corticosteroids in pregnancy: A population-based cohort study","volume":"131","author":"Chi","year":"2011","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.clindermatol.2016.02.006_bb0060","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.jaad.2008.03.018","article-title":"Safety of dermatologic drugs used in pregnant patients with psoriasis and other inflammatory skin diseases","volume":"59","author":"Lam","year":"2008","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2016.02.006_bb0065","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1046\/j.1365-2265.1997.1230939.x","article-title":"Placental 11 beta-hydroxysteroid dehydrogenase: A key regulator of fetal glucocorticoid exposure","volume":"46","author":"Benediktsson","year":"1997","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.clindermatol.2016.02.006_bb0070","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.ejogrb.2009.05.012","article-title":"Pemphigoid gestationis: Current insights into pathogenesis and treatment","volume":"145","author":"Semkova","year":"2009","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.clindermatol.2016.02.006_bb0075","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.2165\/11596240-000000000-00000","article-title":"Rheumatoid arthritis and pregnancy: Safety considerations in pharmacological management","volume":"71","author":"Makol","year":"2011","journal-title":"Drugs"},{"key":"10.1016\/j.clindermatol.2016.02.006_bb0080","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1002\/1096-9926(200012)62:6<385::AID-TERA5>3.0.CO;2-Z","article-title":"Birth defects after maternal exposure to corticosteroids: Prospective cohort study and meta-analysis of epidemiological studies","volume":"62","author":"Park-Wyllie","year":"2000","journal-title":"Teratology"},{"key":"10.1016\/j.clindermatol.2016.02.006_bb0085","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1503\/cmaj.101063","article-title":"Corticosteroid use during pregnancy and risk of orofacial clefts","volume":"183","author":"Hviid","year":"2011","journal-title":"CMAJ"},{"key":"10.1016\/j.clindermatol.2016.02.006_bb0090","doi-asserted-by":"crossref","first-page":"160","DOI":"10.4274\/jcrpe.v3i3.31","article-title":"Fetal adrenal suppression due to maternal corticosteroid use: Case report","volume":"3","author":"Kurtoglu","year":"2011","journal-title":"J Clin Res Pediatr Endocrinol"},{"key":"10.1016\/j.clindermatol.2016.02.006_bb0095","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1210\/er.2008-0014","article-title":"Effects of intrauterine exposure to synthetic glucocorticoids on fetal, newborn, and infant hypothalamic-pituitary-adrenal axis function in humans: A systematic review","volume":"30","author":"Tegethoff","year":"2009","journal-title":"Endocr Rev"},{"key":"10.1016\/j.clindermatol.2016.02.006_bb0100","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1177\/0961203313504637","article-title":"The challenge of pregnancy for patients with SLE","volume":"22","author":"Ateka-Barrutia","year":"2013","journal-title":"Lupus"},{"key":"10.1016\/j.clindermatol.2016.02.006_bb0105","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1542\/peds.108.3.776","article-title":"Transfer of drugs and other chemicals into human milk","volume":"108","author":"American Academy of Pediatrics Committee on Drugs","year":"2001","journal-title":"Pediatrics"},{"key":"10.1016\/j.clindermatol.2016.02.006_bb0110","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.semarthrit.2005.05.002","article-title":"Antirheumatic drugs in pregnancy and lactation","volume":"35","author":"Temprano","year":"2005","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.clindermatol.2016.02.006_bb0115","doi-asserted-by":"crossref","first-page":"431","DOI":"10.2217\/whe.10.24","article-title":"Immunosuppressive medications during pregnancy and lactation in women with autoimmune diseases","volume":"6","author":"Elliott","year":"2010","journal-title":"Womens Health (Lond Engl)"},{"key":"10.1016\/j.clindermatol.2016.02.006_bb0120","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1191\/096120301678646137","article-title":"Hydroxychloroquine (HCQ) in lupus pregnancy: Double-blind and placebo-controlled study","volume":"10","author":"Levy","year":"2001","journal-title":"Lupus"},{"key":"10.1016\/j.clindermatol.2016.02.006_bb0125","doi-asserted-by":"crossref","first-page":"3640","DOI":"10.1002\/art.22159","article-title":"Hydroxychloroquine in lupus pregnancy","volume":"54","author":"Clowse","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.clindermatol.2016.02.006_bb0130","doi-asserted-by":"crossref","DOI":"10.1186\/1546-0096-7-9","article-title":"Systematic review of hydroxychloroquine use in pregnant patients with autoimmune diseases","volume":"7","author":"Sperber","year":"2009","journal-title":"Pediatr Rheumatol Online J"},{"key":"10.1016\/j.clindermatol.2016.02.006_bb0135","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1136\/ard.2008.101766","article-title":"Clinical efficacy and side effects of antimalarials in systemic lupus erythematosus: A systematic review","volume":"69","author":"Ruiz-Irastorza","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.clindermatol.2016.02.006_bb0140","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1517\/14740338.2011.566555","article-title":"Hydroxychloroquine in systemic lupus erythematosus and rheumatoid arthritis and its safety in pregnancy","volume":"10","author":"Abarientos","year":"2011","journal-title":"Expert Opin Drug Saf"},{"key":"10.1016\/j.clindermatol.2016.02.006_bb0145","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/S0140-6736(01)06004-4","article-title":"Ocular toxicity and antenatal exposure to chloroquine or hydroxychloroquine for rheumatic diseases","volume":"358","author":"Klinger","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.clindermatol.2016.02.006_bb0150","doi-asserted-by":"crossref","first-page":"2504","DOI":"10.3899\/jrheum.110686","article-title":"Ocular toxicity in children exposed in utero to antimalarial drugs: Review of the literature","volume":"38","author":"Osadchy","year":"2011","journal-title":"J Rheumatol"},{"key":"10.1016\/j.clindermatol.2016.02.006_bb0155","doi-asserted-by":"crossref","first-page":"3207","DOI":"10.1002\/art.11304","article-title":"Safety of hydroxychloroquine in pregnant patients with connective tissue diseases: A study of one hundred thirty-three cases compared with a control group","volume":"48","author":"Costedoat-Chalumeau","year":"2003","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.clindermatol.2016.02.006_bb0160","first-page":"CD000169","article-title":"Drugs for preventing malaria in pregnant women","author":"Garner","year":"2006","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.clindermatol.2016.02.006_bb0165","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1038\/nrrheum.2009.103","article-title":"Management of RA medications in pregnant patients","volume":"5","author":"Ostensen","year":"2009","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.clindermatol.2016.02.006_bb0170","doi-asserted-by":"crossref","first-page":"633","DOI":"10.2165\/00002018-200427090-00002","article-title":"Dapsone therapy for malaria during pregnancy: Maternal and fetal outcomes","volume":"27","author":"Brabin","year":"2004","journal-title":"Drug Saf"},{"key":"10.1016\/j.clindermatol.2016.02.006_bb0175","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/ibd.22948","article-title":"Systematic review and meta-analysis on the effects of thiopurines on birth outcomes from female and male patients with inflammatory bowel disease","volume":"19","author":"Akbari","year":"2013","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.clindermatol.2016.02.006_bb0180","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1111\/j.1471-0528.1985.tb01088.x","article-title":"Maternal azathioprine therapy and depressed haemopoiesis in the babies of renal allograft patients","volume":"92","author":"Davison","year":"1985","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1016\/j.clindermatol.2016.02.006_bb0185","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1002\/ibd.21154","article-title":"Safety of immunomodulators and biologics for the treatment of inflammatory bowel disease during pregnancy and breast-feeding","volume":"16","author":"Gisbert","year":"2010","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.clindermatol.2016.02.006_bb0190","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1001\/archderm.144.6.783","article-title":"Do safe and effective treatment options exist for patients with active pemphigus vulgaris who plan conception and pregnancy?","volume":"144","author":"Lehman","year":"2008","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clindermatol.2016.02.006_bb0195","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1002\/bdra.20583","article-title":"Early pregnancy azathioprine use and pregnancy outcomes","volume":"85","author":"Cleary","year":"2009","journal-title":"Birth Defects Res A Clin Mol Teratol"},{"key":"10.1016\/j.clindermatol.2016.02.006_bb0200","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.crohns.2010.10.005","article-title":"Long-term follow-up of babies exposed to azathioprine in utero and via breastfeeding","volume":"5","author":"Angelberger","year":"2011","journal-title":"J Crohns Colitis"},{"key":"10.1016\/j.clindermatol.2016.02.006_bb0205","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.clpt.2005.04.014","article-title":"Functional role of P-glycoprotein in the human blood-placental barrier","volume":"78","author":"Molsa","year":"2005","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.clindermatol.2016.02.006_bb0210","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/s40264-013-0034-x","article-title":"Ciclosporin use during pregnancy","volume":"36","author":"Paziana","year":"2013","journal-title":"Drug Saf"},{"key":"10.1016\/j.clindermatol.2016.02.006_bb0215","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.jaad.2011.07.039","article-title":"Review of treatment options for psoriasis in pregnant or lactating women: From the Medical Board of the National Psoriasis Foundation","volume":"67","author":"Bae","year":"2012","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2016.02.006_bb0220","doi-asserted-by":"crossref","first-page":"2480","DOI":"10.1016\/S0041-1345(97)00458-2","article-title":"Analysis of 629 pregnancy outcomes in transplant recipients treated with Sandimmun","volume":"29","author":"Lamarque","year":"1997","journal-title":"Transplant Proc"},{"key":"10.1016\/j.clindermatol.2016.02.006_bb0225","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1016\/S0041-1345(98)00408-4","article-title":"Pregnancy outcomes in female renal transplant recipients","volume":"30","author":"Armenti","year":"1998","journal-title":"Transplant Proc"},{"key":"10.1016\/j.clindermatol.2016.02.006_bb0230","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1097\/00007890-200104270-00006","article-title":"Pregnancy outcome after cyclosporine therapy during pregnancy: A meta-analysis","volume":"71","author":"Bar Oz","year":"2001","journal-title":"Transplantation"},{"key":"10.1016\/j.clindermatol.2016.02.006_bb0235","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/j.jaad.2010.02.062","article-title":"The use of cyclosporine in dermatology: Part II","volume":"63","author":"Ryan","year":"2010","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2016.02.006_bb0240","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1097\/00007890-199801270-00019","article-title":"Breast-feeding during treatment with cyclosporine","volume":"65","author":"Nyberg","year":"1998","journal-title":"Transplantation"},{"key":"10.1016\/j.clindermatol.2016.02.006_bb0245","doi-asserted-by":"crossref","first-page":"2144","DOI":"10.1097\/01.TP.0000066352.86763.D0","article-title":"Cyclosporine excretion into breast milk","volume":"75","author":"Moretti","year":"2003","journal-title":"Transplantation"},{"key":"10.1016\/j.clindermatol.2016.02.006_bb0250","doi-asserted-by":"crossref","first-page":"593","DOI":"10.2340\/00015555-2032","article-title":"Cyclosporine treatment in severe gestational pemphigoid","volume":"95","author":"Huilaja","year":"2015","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.clindermatol.2016.02.006_bb0255","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1001\/archdermatol.2011.1614","article-title":"Narrowband UV-B phototherapy during pregnancy and folic acid depletion","volume":"148","author":"Park","year":"2012","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clindermatol.2016.02.006_bb0260","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1111\/j.1468-3083.2010.03925.x","article-title":"Use of intravenous immunoglobulin therapy during pregnancy in patients with pemphigus vulgaris","volume":"25","author":"Ahmed","year":"2011","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.clindermatol.2016.02.006_bb0265","doi-asserted-by":"crossref","first-page":"2783","DOI":"10.1002\/art.30464","article-title":"Association of the idiotype:antiidiotype antibody ratio with the efficacy of intravenous immunoglobulin treatment for the prevention of recurrent autoimmune-associated congenital heart block","volume":"63","author":"Routsias","year":"2011","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.clindermatol.2016.02.006_bb0270","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1111\/j.1440-0960.2011.00854.x","article-title":"Successful treatment of a severe persistent case of pemphigoid gestationis with antepartum and postpartum intravenous immunoglobulin followed by azathioprine","volume":"53","author":"Gan","year":"2012","journal-title":"Australas J Dermatol"},{"key":"10.1016\/j.clindermatol.2016.02.006_bb0275","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1111\/dth.12073","article-title":"Management of psoriasis in pregnancy","volume":"26","author":"Babalola","year":"2013","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.clindermatol.2016.02.006_bb0280","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1111\/bjd.13060","article-title":"Safety of biological therapies for psoriasis: Effects on reproductive potential and outcomes in male and female patients","volume":"171","author":"Yiu","year":"2014","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2016.02.006_bb0285","doi-asserted-by":"crossref","first-page":"2385","DOI":"10.1111\/j.1572-0241.2004.30186.x","article-title":"Outcome of pregnancy in women receiving infliximab for the treatment of Crohn's disease and rheumatoid arthritis","volume":"99","author":"Katz","year":"2004","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.clindermatol.2016.02.006_bb0290","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1111\/j.1365-2036.2005.02405.x","article-title":"Intentional infliximab use during pregnancy for induction or maintenance of remission in Crohn's disease","volume":"21","author":"Mahadevan","year":"2005","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.clindermatol.2016.02.006_bb0295","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.jbspin.2008.04.016","article-title":"Exposition to anti-TNF drugs during pregnancy: Outcome of 15 cases and review of the literature","volume":"76","author":"Berthelot","year":"2009","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.clindermatol.2016.02.006_bb0300","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1016\/j.jaad.2011.04.030","article-title":"Fatal case of disseminated BCG infection after vaccination of an infant with in utero exposure to infliximab","volume":"65","author":"Heller","year":"2011","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2016.02.006_bb0305","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1093\/rheumatology\/keq403","article-title":"Safety of rituximab therapy during twins' pregnancy","volume":"50","author":"Ton","year":"2011","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.clindermatol.2016.02.006_bb0310","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1182\/blood-2010-07-295444","article-title":"Pregnancy outcomes after maternal exposure to rituximab","volume":"117","author":"Chakravarty","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.clindermatol.2016.02.006_bb0315","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1097\/OGX.0b013e3181bea089","article-title":"Pemphigus vulgaris in pregnancy: Analysis of current data on the management and outcomes","volume":"64","author":"Kardos","year":"2009","journal-title":"Obstet Gynecol Surv"},{"key":"10.1016\/j.clindermatol.2016.02.006_bb0320","first-page":"27","article-title":"Successful immunoapheresis of bullous autoimmune diseases: Pemphigus vulgaris and pemphigoid gestationis","volume":"9","author":"Marker","year":"2011","journal-title":"J Dtsch Dermatol Ges"},{"issue":"A","key":"10.1016\/j.clindermatol.2016.02.006_bb0325","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1002\/ajmg.a.32420","article-title":"Mycophenolate mofetil embryopathy may be dose and timing dependent","volume":"146","author":"Ang","year":"2008","journal-title":"Am J Med Genet A"},{"key":"10.1016\/j.clindermatol.2016.02.006_bb0330","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.det.2011.06.012","article-title":"Mycophenolate mofetil for the management of autoimmune bullous diseases","volume":"29","author":"Eskin-Schwartz","year":"2011","journal-title":"Dermatol Clin"},{"issue":"A","key":"10.1016\/j.clindermatol.2016.02.006_bb0335","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1002\/ajmg.a.35223","article-title":"Teratogenicity of mycophenolate confirmed in a prospective study of the European Network of Teratology Information Services","volume":"158","author":"Hoeltzenbein","year":"2012","journal-title":"Am J Med Genet A"},{"key":"10.1016\/j.clindermatol.2016.02.006_bb0340","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1191\/0961203305lu2169oa","article-title":"Cyclophosphamide for lupus during pregnancy","volume":"14","author":"Clowse","year":"2005","journal-title":"Lupus"},{"issue":"Suppl. 1","key":"10.1016\/j.clindermatol.2016.02.006_bb0345","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s00404-011-1859-0","article-title":"Successful pregnancy after cyclophosphamide therapy for lupus nephritis","volume":"283","author":"Lannes","year":"2011","journal-title":"Arch Gynecol Obstet"},{"key":"10.1016\/j.clindermatol.2016.02.006_bb0350","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.autrev.2010.08.004","article-title":"Pregnancy in autoimmune rheumatic diseases: The importance of counselling for old and new challenges","volume":"10","author":"Andreoli","year":"2010","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.clindermatol.2016.02.006_bb0355","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.autrev.2014.12.011","article-title":"State of the art: Reproduction and pregnancy in rheumatic diseases","volume":"14","author":"Ostensen","year":"2015","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.clindermatol.2016.02.006_bb0360","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.clim.2013.05.006","article-title":"Evaluation and management of systemic lupus erythematosus and rheumatoid arthritis during pregnancy","volume":"149","author":"Barbhaiya","year":"2013","journal-title":"Clin Immunol"},{"key":"10.1016\/j.clindermatol.2016.02.006_bb0365","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1111\/aogs.12158","article-title":"Does cutaneous lupus erythematosus have more favorable pregnancy outcomes than systemic disease? A two-center study","volume":"92","author":"Hamed","year":"2013","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.clindermatol.2016.02.006_bb0370","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1111\/1756-185X.12524","article-title":"Pregnancy-related issues in women with systemic lupus erythematosus","volume":"18","author":"Singh","year":"2015","journal-title":"Int J Rheum Dis"},{"key":"10.1016\/j.clindermatol.2016.02.006_bb0375","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1586\/1744666X.2015.1033404","article-title":"Immunosuppression in pregnant women with systemic lupus erythematosus","volume":"11","author":"Ponticelli","year":"2015","journal-title":"Expert Rev Clin Immunol"},{"key":"10.1016\/j.clindermatol.2016.02.006_bb0380","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/s00404-010-1618-7","article-title":"Pregnancy outcome in systemic lupus erythematosus: Asia's largest single centre study","volume":"284","author":"Aggarwal","year":"2011","journal-title":"Arch Gynecol Obstet"},{"key":"10.1016\/j.clindermatol.2016.02.006_bb0385","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.reuma.2014.11.005","article-title":"Clinical practice guidelines for the management of pregnancy in women with autoimmune rheumatic diseases of the Mexican College of Rheumatology. Part I","volume":"11","author":"Saavedra Salinas","year":"2015","journal-title":"Reumatol Clin"},{"key":"10.1016\/j.clindermatol.2016.02.006_bb0390","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.jcma.2014.11.008","article-title":"Pregnancy outcome of systemic lupus erythematosus in relation to lupus activity before and during pregnancy","volume":"78","author":"Yang","year":"2015","journal-title":"J Chin Med Assoc"},{"key":"10.1016\/j.clindermatol.2016.02.006_bb0395","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1177\/0961203315586455","article-title":"Specific systemic lupus erythematosus disease manifestations in the six months prior to conception are associated with similar disease manifestations during pregnancy","volume":"24","author":"Tedeschi","year":"2015","journal-title":"Lupus"},{"key":"10.1016\/j.clindermatol.2016.02.006_bb0400","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1007\/s12026-014-8572-6","article-title":"Predictors of maternal and fetal complications in SLE patients: A prospective study","volume":"60","author":"Borella","year":"2014","journal-title":"Immunol Res"},{"key":"10.1016\/j.clindermatol.2016.02.006_bb0405","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.berh.2013.07.005","article-title":"Managing lupus patients during pregnancy","volume":"27","author":"Lateef","year":"2013","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"10.1016\/j.clindermatol.2016.02.006_bb0410","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1177\/0961203314555352","article-title":"Hydroxychloroquine and pregnancy on lupus flares in Korean patients with systemic lupus erythematosus","volume":"24","author":"Koh","year":"2015","journal-title":"Lupus"},{"key":"10.1016\/j.clindermatol.2016.02.006_bb0415","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1177\/0961203315591027","article-title":"Impact of hydroxychloroquine on preterm delivery and intrauterine growth restriction in pregnant women with systemic lupus erythematosus: A descriptive cohort study","volume":"24","author":"Leroux","year":"2015","journal-title":"Lupus"},{"key":"10.1016\/j.clindermatol.2016.02.006_bb0420","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1007\/s10067-015-2987-x","article-title":"Azathioprine during pregnancy in systemic lupus erythematosus patients is not associated with poor fetal outcome","volume":"34","author":"Saavedra","year":"2015","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.clindermatol.2016.02.006_bb0425","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.reuma.2014.12.004","article-title":"Clinical practice guidelines for the management of pregnancy in women with autoimmune rheumatic diseases of the Mexican College of Rheumatology. Part II","volume":"11","author":"Saavedra Salinas","year":"2015","journal-title":"Reumatol Clin"},{"key":"10.1016\/j.clindermatol.2016.02.006_bb0430","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.rbr.2014.10.001","article-title":"Pregnancy outcomes in dermatomyositis and polymyositis patients","volume":"55","author":"Missumi","year":"2015","journal-title":"Rev Bras Reumatol"},{"key":"10.1016\/j.clindermatol.2016.02.006_bb0435","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s00296-009-1166-2","article-title":"Intravenous immunoglobulin treatment for pregnancy-associated dermatomyositis","volume":"31","author":"Linardaki","year":"2011","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.clindermatol.2016.02.006_bb0440","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1007\/s00296-006-0239-8","article-title":"Pregnancy outcome in idiopathic inflammatory myopathy","volume":"27","author":"Vancsa","year":"2007","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.clindermatol.2016.02.006_bb0445","first-page":"17","article-title":"Autoimmune inflammatory myopathy in pregnancy","volume":"10","author":"Chopra","year":"2008","journal-title":"Medscape J Med"},{"key":"10.1016\/j.clindermatol.2016.02.006_bb0450","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1002\/art.20913","article-title":"Pregnant patient with dermatomyositis successfully treated with intravenous immunoglobulin therapy","volume":"53","author":"Mosca","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.clindermatol.2016.02.006_bb0455","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.3899\/jrheum.140583","article-title":"Disease severity and pregnancy outcomes in women with rheumatoid arthritis: Results from the Organization of Teratology Information Specialists Autoimmune Diseases in Pregnancy Project","volume":"42","author":"Bharti","year":"2015","journal-title":"J Rheumatol"},{"key":"10.1016\/j.clindermatol.2016.02.006_bb0460","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1177\/1759720X14551568","article-title":"Use of DMARDs and biologics during pregnancy and lactation in rheumatoid arthritis: What the rheumatologist needs to know","volume":"6","author":"Krause","year":"2014","journal-title":"Ther Adv Musculoskelet Dis"},{"key":"10.1016\/j.clindermatol.2016.02.006_bb0465","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.jaad.2004.07.023","article-title":"Rheumatoid arthritis: A review of the cutaneous manifestations","volume":"53","author":"Sayah","year":"2005","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2016.02.006_bb0470","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1080\/08998280.2015.11929308","article-title":"Acral vesicles and bullae in a patient with severe rheumatoid arthritis","volume":"28","author":"Soza","year":"2015","journal-title":"Proc (Bayl Univ Med Cent)"},{"key":"10.1016\/j.clindermatol.2016.02.006_bb0475","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1590\/abd1806-4841.20153263","article-title":"Interstitial granulomatous dermatitis: Rare cutaneous manifestation of rheumatoid arthritis","volume":"90","author":"Veronez","year":"2015","journal-title":"An Bras Dermatol"},{"key":"10.1016\/j.clindermatol.2016.02.006_bb0480","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1097\/BOR.0000000000000054","article-title":"Non-steroidal antiinflammatory drugs, glucocorticoids and disease modifying anti-rheumatic drugs for the management of rheumatoid arthritis before and during pregnancy","volume":"26","author":"Bermas","year":"2014","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.clindermatol.2016.02.006_bb0485","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1097\/BOR.0000000000000046","article-title":"Rheumatoid arthritis and pregnancy: Impediments to optimal management of both biologic use before, during and after pregnancy","volume":"26","author":"Williams","year":"2014","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.clindermatol.2016.02.006_bb0490","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1093\/rheumatology\/ket475","article-title":"Vasculitis associated with rheumatoid arthritis: A case\u2013control study","volume":"53","author":"Makol","year":"2014","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.clindermatol.2016.02.006_bb0495","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.rdc.2007.03.001","article-title":"Pregnancy in scleroderma","volume":"33","author":"Steen","year":"2007","journal-title":"Rheum Dis Clin North Am"},{"key":"10.1016\/j.clindermatol.2016.02.006_bb0500","doi-asserted-by":"crossref","first-page":"580","DOI":"10.7861\/clinmedicine.13-6-580","article-title":"Connective tissue disease in pregnancy","volume":"13","author":"Ateka-Barrutia","year":"2013","journal-title":"Clin Med"},{"key":"10.1016\/j.clindermatol.2016.02.006_bb0505","first-page":"99","article-title":"Comprehensive approach to systemic sclerosis patients during pregnancy","volume":"11","author":"Rueda de Leon Aguirre","year":"2015","journal-title":"Reumatol Clin"},{"key":"10.1016\/j.clindermatol.2016.02.006_bb0510","doi-asserted-by":"crossref","first-page":"A515","DOI":"10.1016\/j.autrev.2011.11.021","article-title":"Pregnancy issues in scleroderma","volume":"11","author":"Lidar","year":"2012","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.clindermatol.2016.02.006_bb0515","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1093\/rheumatology\/keu394","article-title":"High-risk pregnancy and the rheumatologist","volume":"54","author":"Soh","year":"2015","journal-title":"Rheumatology (Oxford)"},{"issue":"Suppl. 3","key":"10.1016\/j.clindermatol.2016.02.006_bb0520","first-page":"iii16","article-title":"Pregnancy in systemic sclerosis","volume":"47","author":"Miniati","year":"2008","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.clindermatol.2016.02.006_bb0525","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.rdc.2005.04.001","article-title":"Pregnancy in mixed connective tissue disease","volume":"31","author":"Kitridou","year":"2005","journal-title":"Rheum Dis Clin North Am"},{"key":"10.1016\/j.clindermatol.2016.02.006_bb0530","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.det.2011.06.008","article-title":"Management of autoimmune blistering diseases in pregnancy","volume":"29","author":"McPherson","year":"2011","journal-title":"Dermatol Clin"},{"key":"10.1016\/j.clindermatol.2016.02.006_bb0535","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1097\/00006254-199510000-00023","article-title":"Pemphigus vulgaris and pregnancy","volume":"50","author":"Ruach","year":"1995","journal-title":"Obstet Gynecol Surv"},{"key":"10.1016\/j.clindermatol.2016.02.006_bb0540","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1001\/archderm.1992.01680210040004","article-title":"Pemphigus foliaceus. Use of antimalarial agents as adjuvant therapy","volume":"128","author":"Hymes","year":"1992","journal-title":"Arch Dermatol"}],"container-title":["Clinics in Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0738081X16300219?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0738081X16300219?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,4]],"date-time":"2019-09-04T07:35:07Z","timestamp":1567582507000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0738081X16300219"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5]]},"references-count":108,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,5]]}},"alternative-id":["S0738081X16300219"],"URL":"https:\/\/doi.org\/10.1016\/j.clindermatol.2016.02.006","relation":{},"ISSN":["0738-081X"],"issn-type":[{"value":"0738-081X","type":"print"}],"subject":[],"published":{"date-parts":[[2016,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Management of rheumatic and autoimmune blistering disease in pregnancy and postpartum","name":"articletitle","label":"Article Title"},{"value":"Clinics in Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clindermatol.2016.02.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}